Joerg Striessnig

Cited by

	All	Since 2019
Citations	27904	8800
h-index	87	46
i10-index	201	115

1800

900

450

1350

1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202492 236 226 167 197 238 274 259 237 268 347 371 319 382 342 399 448 613 733 723 823 702 722 835 921 1026 1000 1153 1141 1063 1269 1277 1338 1498 1800 1597 1470 1087

Public access

View all

99 articles

3 articles

available

not available

Based on funding mandates

Co-authors

Hartmut GlossmannFull Professor M.D. PhD. Qualified Specialist In Pharmacology,Toxicology and Clinical PharmacologyVerified email at i-med.ac.at
Matteo Elia MANGONIDirecteur de Recherche CNRS, Institut de Génomique Fonctionnelle, Université de MontpellierVerified email at igf.cnrs.fr
Hans-Günther KnausMedizinische Universität InnsbruckVerified email at i-med.ac.at
Nicolas SingewaldDepartment of Pharmacology & Toxicology, Univ of InnsbruckVerified email at uibk.ac.at
Petronel TulucAssoc. Prof. Dep. Pharmacology and Toxicology, Innsbruck UniversityVerified email at uibk.ac.at
Edward Perez-ReyesProfessor of Pharmacology, University of VirginiaVerified email at virginia.edu
Emilio CarboneProfessor of Physiology, Department of Drug Science, University of TorinoVerified email at unito.it
Anneliese Schrott-FischerMedical University of InnsbruckVerified email at i-med.ac.at
Prof David R. FerryVP-Gastrointestinal OncologyVerified email at lilly.com
Gerald ZernigAssoc Prof Pharmacol Toxicol, MD, Psychotherapist, Medical University of InnsbruckVerified email at zerniglabor.at
Emmanuel BourinetIGFUniversité de Montpellier CNRS UMR5203 Inserm U1191Verified email at igf.cnrs.fr
Christoph RomaninProfessor of Biophysics, Johannes Kepler University LinzVerified email at jku.at
Annette C DolphinProfessor of Pharmacology, University College LondonVerified email at ucl.ac.uk
Simone SartoriUniversity of InnsbruckVerified email at uibk.ac.at
Stefan HerzigAlt-Präsident TH Köln, Professor emeritus für Pharmakologie, Universität zu KölnVerified email at uni-koeln.de
Tobias MoserInstitute for Auditory Neuroscience, University Medical Center GöttingenVerified email at gwdg.de
paola carreraGroup Leader, Ospedale San Raffaele, MilanoVerified email at hsr.it
Thierry LangerUniversity of Innsbruck, University of ViennaVerified email at univie.ac.at
Sebastian BargMedical Cell Biology, Uppsala UniversityVerified email at mcb.uu.se
Eckhard FriaufSenior Professor of Animal Physiology - Neurobiology; RPTU Kaiserslautern-LandauVerified email at biologie.uni-kl.de

Joerg Striessnig

University of Innsbruck, Austria

Verified email at uibk.ac.at - Homepage

Ion Channel Pharmacology Calcium Signaling Calcium Channels


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels WA Catterall, E Perez-Reyes, TP Snutch, J Striessnig Pharmacological reviews 57 (4), 411-425, 2005	1692	2005
Purification, molecular cloning, and expression of the mammalian sigma1-binding site. M Hanner, FF Moebius, A Flandorfer, HG Knaus, J Striessnig, E Kempner, ... Proceedings of the National Academy of Sciences 93 (15), 8072-8077, 1996	1152	1996
The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential GW Zamponi, J Striessnig, A Koschak, AC Dolphin Pharmacological reviews 67 (4), 821-870, 2015	1112	2015
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels J Platzer, J Engel, A Schrott-Fischer, K Stephan, S Bova, H Chen, ... Cell 102 (1), 89-97, 2000	1092	2000
Neurobiology of migraine D Pietrobon, J Striessnig Nature Reviews Neuroscience 4 (5), 386-398, 2003	796	2003
Functional role of L-type Ca_v1.3 Ca²⁺ channels in cardiac pacemaker activity ME Mangoni, B Couette, E Bourinet, J Platzer, D Reimer, J Striessnig, ... Proceedings of the National Academy of Sciences 100 (9), 5543-5548, 2003	587	2003
α1D (Cav1. 3) subunits can form L-type Ca2+ channels activating at negative voltages A Koschak, D Reimer, I Huber, M Grabner, H Glossmann, J Engel, ... Journal of Biological Chemistry 276 (25), 22100-22106, 2001	558	2001
Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension EAB Azizan, H Poulsen, P Tuluc, J Zhou, MV Clausen, A Lieb, C Maniero, ... Nature genetics 45 (9), 1055-1060, 2013	544	2013
Pharmacological disruption of calcium channel trafficking by the α2δ ligand gabapentin J Hendrich, AT Van Minh, F Heblich, M Nieto-Rostro, K Watschinger, ... Proceedings of the National Academy of Sciences 105 (9), 3628-3633, 2008	505	2008
Receptor sites for Ca2+ channel antagonists WA Catterall, J Striessnig Trends in pharmacological sciences 13, 256-262, 1992	487	1992
CaV1. 3 channels are essential for development and presynaptic activity of cochlear inner hair cells A Brandt, J Striessnig, T Moser Journal of Neuroscience 23 (34), 10832-10840, 2003	474	2003
The Concise Guide to PHARMACOLOGY 2019/20: Introduction and other protein targets SPH Alexander, E Kelly, A Mathie, JA Peters, EL Veale, JF Armstrong, ... British journal of pharmacology 176, S1-S20, 2019	431	2019
Functional embryonic cardiomyocytes after disruption of the L-type α1C (Cav 1.2) calcium channel gene in the mouse C Seisenberger, V Specht, A Welling, J Platzer, A Pfeifer, S Kuhbandner, ... Journal of Biological Chemistry 275 (50), 39193-39199, 2000	381	2000
Loss of Ca_v1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness SM Baig, A Koschak, A Lieb, M Gebhart, C Dafinger, G Nürnberg, A Ali, ... Nature neuroscience 14 (1), 77-84, 2011	371	2011
International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels WA Catterall, J Striessnig, TP Snutch, E Perez-Reyes Pharmacological reviews 55 (4), 579-581, 2003	357	2003
The concise guide to pharmacology 2019/20: Ion channels SPH Alexander, A Mathie, JA Peters, EL Veale, J Striessnig, E Kelly, ... British journal of pharmacology 176, S142-S228, 2019	354	2019
Familial hemiplegic migraine mutations increase Ca²⁺ influx through single human Ca_V2.1 channels and decrease maximal Ca_V2.1 current density in neurons A Tottene, T Fellin, S Pagnutti, S Luvisetto, J Striessnig, C Fletcher, ... Proceedings of the National Academy of Sciences 99 (20), 13284-13289, 2002	342	2002
Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain CS Müller, A Haupt, W Bildl, J Schindler, HG Knaus, M Meissner, ... Proceedings of the National Academy of Sciences 107 (34), 14950-14957, 2010	341	2010
Familial Hemiplegic Migraine Mutations Change α1ACa2+ Channel Kinetics RL Kraus, MJ Sinnegger, H Glossmann, S Hering, J Striessnig Journal of Biological Chemistry 273 (10), 5586-5590, 1998	338*	1998
Structural basis of drug binding to L Ca2+ channels J Striessnig, M Grabner, J Mitterdorfer, S Hering, MJ Sinnegger, ... Trends in pharmacological sciences 19 (3), 108-115, 1998	328	1998

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors